. . . . . . . . . . . . "[BRAF mutation testing may also add additional information for differential diagnosis of primary brain tumors in selected situations, e.g., for differentiation of anaplastic pleomorphic xanthoastrocytoma (BRAF V600E mutation in 65%) from glioblastoma (BRAF V600E mutation in < 5%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2014-02-25"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2014-10-02T12:37:41+02:00"^^ . . . . . . . . . . . "v2.1.0.0" . "v2.1.0" .